摘要
钠氢离子交换器和水通道蛋白在病理生理情况下,都是关键的细胞体积和细胞内离子的调节者。特别是亚型1通过直接影响水和离子交换穿过质膜、钠氢离子交换器和水通道蛋白,并对几种类型的刺激反应的应答如高渗应激,可以同时影响血管张力和细胞骨架。钠氢离子交换器1与水通道蛋白1主要在心血管系统中的表达。他们在升高的细胞外液渗透压的过度激活,对微血管和大血管内皮细胞均有害,如糖尿病高血糖的发生。虽然钠氢离子通道泵-1和水通道蛋白1调节细胞内体积和离子,它们也是影响高渗性相关基因的激活和参与葡萄糖毒性及血管损伤细胞的功能。由于对钠氢离子交换器和水通道蛋白参与微血管和大血管疾病,包括高血压和动脉粥样硬化斑块不稳定,研究的重点是开发这些转运蛋白抑制剂。为开发可以治疗糖尿病动脉粥样硬化的新药物,我们回顾现有的水通道蛋白的生物方面和调控机制,包括其潜在目标的研究。
关键词: 水通道蛋白,动脉粥样硬化,糖尿病,高渗应激,钠氢离子交换器。
Current Drug _targets
Title:Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological _targets in Diabetic Atherosclerosis
Volume: 16 Issue: 4
Author(s): Rosalinda Madonna and Raffaele De Caterina
Affiliation:
关键词: 水通道蛋白,动脉粥样硬化,糖尿病,高渗应激,钠氢离子交换器。
摘要: Sodium-hydrogen exchangers (NHEs) and aquaporins (AQPs) are key regulators of cell volume and intracellular ions both in physiological and pathological conditions. By directly affecting water and ion exchanges across the plasma membrane, NHEs and AQPs, particularly isoforms 1, can also influence vascular tone and the cytoskeleton, respectively, in response to several types of stimuli, such as hypertonic stress. NHE-1 and AQP1 are mainly expressed in tissues of the cardiovascular system. Their excessive activation in response to elevated extracellular osmolarity, as occurring in diabetic hyperglycemia, can be deleterious both for micro- and macrovascular endothelial cells. Although NHE-1 and AQP1 regulate the intracellular volume and ions, they also influence the activation of hypertonicity-responsive genes and cell functions involved in glucotoxicity and vascular injury. Because of the involvement of NHEs and AQPs in micro- and macrovascular disease, including arterial hypertension and atherosclerotic plaque destabilization, research has focused on developing inhibitors of these transporters. We here review current knowledge of NHEs and AQPs investigating biological aspects and mechanisms of their regulation, including their potential as _target for developing new drugs that could _target diabetic atherosclerosis.
Export Options
About this article
Cite this article as:
Rosalinda Madonna and Raffaele De Caterina , Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological _targets in Diabetic Atherosclerosis, Current Drug _targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450116666141219115720
DOI https://dx.doi.org/10.2174/1389450116666141219115720 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein disulfide isomerase and Nox: new partners in redox signaling
Current Pharmaceutical Design Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Current Diabetes Reviews Patents on Therapeutic and Cosmetic Applications of Bioactives of Crocus Sativus L. and their Production through Synthetic Biology Methods: A Review
Recent Patents on Biotechnology Functions of the Third Intracellular Loop of the Human Melanocortin-3 Receptor
Current Pharmaceutical Design PAI-1 Antagonists: Predictable Indications and Unconventional Applications
Current Drug _targets Protective Effects of Pomegranate in Endothelial Dysfunction
Current Pharmaceutical Design Medicinal Plants and Bioactive Compounds for Diabetes Management: Important Advances in Drug Discovery
Current Pharmaceutical Design Electronic Cigarettes <i>Versus</i> Tobacco Poly Use: Reduced Oxidative Stress but Similar Inflammatory Effect
New Emirates Medical Journal Postprandial Glucose - A Potential Therapeutic _target to Reduce Cardiovascular Mortality
Current Vascular Pharmacology ATP-Sensitive K+ Channels: Current and Putative _target for the Prevention and Treatment of Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) In Vitro Data of Current Therapies for SARS-CoV-2
Current Medicinal Chemistry A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin – Molecular Mechanisms
Current Pharmaceutical Biotechnology Mediterranean Diet And Longevity: An Example Of Nutraceuticals?
Current Vascular Pharmacology Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Current Respiratory Medicine Reviews Editorial (Thematic Issue: Enantioselective Synthesis in Organic and Medicinal Chemistry)
Current Topics in Medicinal Chemistry A Review of Medicinal Plants and Phytochemicals for the Management of Gout
Current Rheumatology Reviews Rationally Designed Multi_target Agents Against Inflammation and Pain
Current Medicinal Chemistry Angiotensin-(1-7): Blood, Heart, and Blood Vessels
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions
Current Cardiology Reviews